Live Stream Learning with Simulations Plus - Day One Simulations Plus, Inc.

204 views - 5 years ago

Live Stream Learning with Simulations Plus - Day Two Simulations Plus, Inc.

121 views - 5 years ago

Developing Biosimilars: How to Design PK and PD Similarity Studies Using Modeling & Simulation Simulations Plus, Inc.

93 views - 3 weeks ago

Simulations Plus 2021 Simulations Plus, Inc.

2.7K views - 5 years ago

Simulations Plus, Inc SLP Q1 2026 Earnings Call Fyfull

1 views - 1 month ago

Semi-Mechanistic PK/PD Model Effect Odanacatib, a Cathespin K Inhibtor, on Bone Turnover Simulations Plus, Inc.

183 views - 4 years ago

More to come in 2022 for Simulations Plus! Simulations Plus, Inc.

74 views - 4 years ago

Simulations Plus' software can fast-track the regulatory process for new drugs Proactive Investors

1.2K views - 7 years ago

MIDD+ 2023 Agenda is now live! Simulations Plus, Inc.

67 views - 3 years ago

Simulations Plus - Company Overview Simulations Plus, Inc.

4.9K views - 9 years ago

Simulations Plus Services Simulations Plus, Inc.

137 views - 4 years ago

Simulations Plus Celebrates 25 Years in Business Simulations Plus, Inc.

78 views - 4 years ago

Simulations Plus News & Events April 2019 Simulations Plus, Inc.

96 views - 6 years ago

Introduction to Reprise Licensing Simulations Plus, Inc.

35 views - 1 month ago

Simulations Plus Welcome Sandra Suarez-Sharp VP of Regulatory Affairs Simulations Plus, Inc.

618 views - 5 years ago

Supplier Insider: Simulations Plus Simulations Plus, Inc.

190 views - 5 years ago

Real-world Considerations in Pharma for QSP Modeling Simulations Plus, Inc.

490 views - 4 years ago

GPX.2: Using P-PSD™ to Fit Product Particle Size for In Vivo Dissolution Prediction Simulations Plus, Inc.

112 views - 3 months ago

Simulations Plus News and Events October 2019 Simulations Plus, Inc.

190 views - 6 years ago

$SLP Simulations Plus Q1 2026 Earnings Conference Call EARNMOAR

27 views - 1 month ago